On June 29th, the award ceremony for the VB-Link Future Medical Specialty Innovative Solution Challenge (hereinafter referred to as the VB-Link Competition) was held at the Intercontinental Hotel in Jiabao, Tianjin Economic-Technological Development Area. After intense competition at the national finals, Hopstem's "iPSC Cell Therapy Products and Organoids Platform" project won the third prize in the field of neurology.
Based on the winning projects of this competition, they cover various areas such as innovative medical devices, biopharmaceuticals, and digital therapies, including organoids platforms, plant intervention devices, ophthalmic surgical robots, gene therapy drugs, etc. The types are diverse and novel, injecting fresh blood into the industry for high-quality development.
Mechanism study of hNPC01 neural progenitor cell grafting therapy in a rat ischemic stroke model was published in Nature Communications
Hopstem Won First Place at 2024 SAPA Investment Forum & online Road Show with Innovative iPSC Cell Therapy for Chronic Stroke
Hopstem Biotechnology at 2024 CASSS CGPT Symposium
Hopstem Biotechnology to Participate in the 2024 BIO International Convention in San Diego